Snehal Shah

Efforts to catalyse climate investment in the Global South are starting to bear fruit.

Having helped the impact investing industry to scale and institutionalise, CalSTRS, Capricorn, Builders Vision, Makena and Accelerate are finding new investment avenues for the industry's growth.

Meier, who oversees assets worth $272bn, believes private equity's fees are 'too high'.

Meier, who oversees assets worth $272bn, believes private equity's fees are 'too high'.

Responsible use of AI requires ‘better accuracy, better validation, better controls', says one GP's head of ESG.

Climate tech founders should take advantage of government grants and incentives and add software components to their businesses, venture firm managers advised at New York Climate Week.

Founders can look to asset owners, corporations, government funding and project and equipment finance to scale their operations.

BackgroundDydrogesterone, an oral selective progesterone receptor agonist with high bioavailability, has been used since the 1960s to treat various conditions arising due to the deficiency of progesterone. Patients are expected to have additional compliance and reduced pill burden with dydrogesterone 20 mg and 30 mg SR once a day (OD) for conditions requiring 10 mg twice a day (BID) or thrice a day (TID).MethodologyA real-world analysis was conducted using the HealthPlix electronic medical records (EMR) database to understand the demography, indications, and prescription patterns of dydrogesterone 20 mg and 30 mg SR, including co-prescriptions.ResultsThe mean age of the female patients prescribed dydrogesterone 20 mg SR was 27.23 ± 4.79 years while those prescribed 30 mg SR had a mean age of 28.56 ± 5.17 years. Common indications for the prescription of dydrogesterone 20 mg SR were pregnancy, infertility, and abortion/miscarriage. Pregnancy, infertility, and amenorrhea were the common conditions for dydrogesterone 30 mg SR prescription. The average duration of prescription of dydrogesterone 20 mg and 30 mg SR was 55.50 ± 31.33 and 79.66 ± 68.38 days, respectively. OD regimen was the preferred regimen for dydrogesterone 20 mg SR (89.48%) and dydrogesterone 30 mg SR (64.06%).ConclusionsThis analysis suggests dydrogesterone 20 mg and 30 mg SR are being prescribed for various indications in the real world with significant variation in the prescription patterns.

Private equity giants such as TPG, Brookfield and KKR are raising billions for climate and impact themes, even as a US election threatens to upend global climate action.

It's crunch time for impact private equity fund managers as they face restive limited partners, volatile economic conditions and few ways to exit their current portfolio investments.